# Endocannabinoid System & Maternal Cytokines: Clinical Research > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/maternal-immune-suppression-cannabis-pregnancy/ > **Published:** 2026-03-04T12:01:37-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T12:00:53-04:00 > **Clinical Summary:** Explore maternal immune suppression cannabis use during pregnancy and its impact on cytokines and maternal health in clinical research. --- #### Clinical Takeaway [Cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) during pregnancy is associated with measurable suppression of key immune signaling proteins (cytokines) in the mother’s bloodstream, findings confirmed through urine-verified exposure. Because the immune system plays a critical role in supporting a healthy pregnancy, any suppression of maternal immune function raises legitimate clinical concern. Pregnant patients should be counseled that [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) is not without biological consequence to maternal physiology, regardless of perceived safety. ### #25 Cannabis Use During Pregnancy Is Associated with the Suppression of Circulating Maternal Cytokines. **Citation:** Alshaarawy Omayma et al. *Cannabis Use During Pregnancy Is Associated with the Suppression of Circulating Maternal Cytokines.* Cannabis and [cannabinoid research](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/). 2026. PMID: 41104491. **Study type:** Journal Article  |  **Topic area:** Pediatrics  |  **CED Score:** 10 Design: 0 Journal: 1 N: 2 Recency: 3 Pop: 3 Human: 1 Risk: 0 **Abstract:** INTRODUCTION: The prevalence of [prenatal cannabis use](https://cedclinic.com/placental-biology-prenatal-thc-exposure-schizophrenia-risk/) has nearly doubled in the United States. Cannabinoid 2 receptors are predominately expressed in cells of the human immune system, and delta-9 tetrahydrocannabinol (THC), the primary active component of cannabis, has been shown to suppress immune responses. Despite these findings, there is very little evidence on the impact of cannabis use on maternal immune system. Here, we evaluate the association between urine-verified cannabis use and the levels of T helper cytokines in the maternal circulation. METHODS: This was an ancillary study of a prospective cohort of pregnant women who participated in the Michigan Archive for Research on Child Health study. Pregnant women (age ≥18 years) were recruited from 22 prenatal clinics in Michigan and matched on age, race, and tobacco smoking (n = 144). The urinary metabolite of delta-9 THC, 11-nor-9-carboxy-delta-9-THC (THC-COOH), was used to define cannabis use status. A bead-based assay was used for the simultaneous detection of maternal cytokines associated with cannabis use and pregnancy outcomes in previous studies. RESULTS: Repeated-measures linear mixed models indicated that urine-verified cannabis use was associated with the suppression of maternal pro-inflammatory cytokines including interferon gamma (β = -0.5; 95% confidence interval [CI] = -0.8, -0.1) and interleukin (IL)-12 (β = -0.3; 95% CI = -0.6, -0.05), as well as the anti-inflammatory IL-4 (β = -0.7; 95% CI = -1.3, -0.2) and IL-10 (β = -0.4; 95% CI = -0.7, -0.03). Similar results were observed when heavy cannabis use was defined using the top tertile of urinary THC-COOH at each trimester. CONCLUSIONS: Urine-verified cannabis use was associated with the suppression of pro- and anti-inflammatory T helper cytokines in a cohort of pregnant women, suggesting that cannabis use can lead to modest dysregulation of the maternal immune system. Additional studies are needed to investigate the role of maternal immune resp [Full Article](https://doi.org/10.1177/25785125251388764)  |  [PubMed](https://pubmed.ncbi.nlm.nih.gov/41104491/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Endocannabinoid System: Cannabis, Pregnancy & Cytokines](https://cedclinic.com/cannabis-use-during-pregnancy-maternal-cytokines-impact/) Detailed exploration of cannabis effects on pregnancy and cytokine regulation within the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/). [Read More](https://cedclinic.com/cannabis-use-during-pregnancy-maternal-cytokines-impact/) [Endocannabinoid System Research: Pregnancy Cannabis Effects](https://cedclinic.com/maternal-cannabis-exposure-risk-asd-adhd-offspring/) Comprehensive research on how cannabis use during pregnancy affects the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) and [maternal health](https://cedclinic.com/recreational-cannabis-birth-outcomes-study-colorado/). [Explore Research](https://cedclinic.com/maternal-cannabis-exposure-risk-asd-adhd-offspring/) [Maternal Cannabis Exposure and Risk of ASD ADHD in Offspring](https://cedclinic.com/maternal-cannabis-exposure-risk-asd-offspring/) Systematic review of endocannabinoid system research linking maternal cannabis exposure to neurodevelopmental risks in children. [Learn More](https://cedclinic.com/maternal-cannabis-exposure-risk-asd-offspring/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Endocannabinoid%20System%20%26%20Maternal%20Cytokines%3A%20Clinical%20Research&url=https%3A%2F%2Fcedclinic.com%2Fmaternal-immune-suppression-cannabis-pregnancy%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fmaternal-immune-suppression-cannabis-pregnancy%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Endocannabinoid%20System%20%26%20Maternal%20Cytokines%3A%20Clinical%20Research%20https%3A%2F%2Fcedclinic.com%2Fmaternal-immune-suppression-cannabis-pregnancy%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).